• Log Out Log In
  • T. Rowe Price Health Sciences Fund (PRHSX)
    Ticker Symbol:
    PRHSX
    Fund Status:
    Open to new Retail investors  /  Open to subsequent Retail investments
    Fund Composition
    Asset Allocation
    as of 09/30/2014
    Domestic Stock 88.9%
    Foreign Stock 7.5%
    Cash 3.4%
    Convertibles 0.3%
    Foreign Bonds 0.0%
    Preferreds 0.0%
    Options -0.1%
    Volatility and Other Measures
    as of 10/31/2014
    Beta 1.04
    0.47
    Standard Deviation 13.58
    Price/Earnings Ratio (Domestic) 20.3
    Earnings Growth Rate (Domestic) 15
    Turnover Rate 39.5
    Median Market
    Capitalization
    $29,018.77 Million
    10 Largest Holdings
    Represents 34.36 % of Total Net Assets
    View Holdings as of:
    Actavis plc
    Aetna
    Alexion Pharmaceuticals
    Allergan Inc/United States
    Biogen Idec
    Gilead Sciences
    McKesson
    Puma Biotechnology
    UnitedHealth Group
    Valeant Pharmaceuticals International
    As of 09/30/2014 the Health Sciences Fund had a total of 154 holdings.
    Sector Diversification
    as of 10/31/2014
    % of Total Net Assets
    Biotechnology 32.5%
    Services 24.5%
    Pharmaceuticals 22.1%
    Products & Devices 11.7%
    Life Sciences 4.2%
    Miscellaneous 2.7%
    See Glossary for additional details on all data elements.